Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pol Specenier. (2017) Pembrolizumab use for the treatment of advanced melanoma. Expert Opinion on Biological Therapy 17:6, pages 765-780.
Read now
Read now
Pol Specenier. (2016) Ipilimumab in melanoma. Expert Review of Anticancer Therapy 16:8, pages 811-826.
Read now
Read now
Claire Roddie & Karl S Peggs. (2014) Emerging options for the treatment of melanoma – focus on ipilimumab. ImmunoTargets and Therapy 3, pages 67-78.
Read now
Read now
Articles from other publishers (3)
Esther Bastiaannet, Nicolò Battisti, Kah Poh Loh, Nienke de Glas, Enrique Soto-Perez-de-Celis, Capucine Baldini, Ellen Kapiteijn & Stuart Lichtman. (2019) Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper. Journal of Geriatric Oncology 10:3, pages 389-397.
Crossref
Crossref
Cassandra C. Skinner, Elizabeth L. McMichael, Alena C. Jaime-Ramirez, Zachary B. Abrams, Robert J. Lee & William E. Carson. (2016) Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions. Melanoma Research 26:4, pages 329-337.
Crossref
Crossref
Isabel Heidegger, Petra Massoner, Iris E. Eder, Andreas Pircher, Renate Pichler, Friedrich Aigner, Jasmin Bektic, Wolfgang Horninger & Helmut Klocker. (2013) Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 138, pages 248-256.
Crossref
Crossref